EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit After Tax | ₹707 Cr | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr |
What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?
Year | Profit After Tax |
---|---|
Mar2025 | ₹707 Cr |
Mar2024 | ₹528 Cr |
Mar2023 | ₹562 Cr |
Mar2022 | ₹703 Cr |
Mar2021 | ₹419 Cr |
How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹707 Cr | 34.10 | |
Mar2024 | ₹528 Cr | -6.10 | |
Mar2023 | ₹562 Cr | -20.03 | |
Mar2022 | ₹703 Cr | 67.84 | |
Mar2021 | ₹419 Cr | - |
Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹26,507.3 Cr | 2.6% | 11.4% | 9.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -1.9% | -4.1% | -6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -3.6% | -12.3% | 27.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -2.1% | 7.2% | 9.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -0.7% | -0% | -2.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -1.6% | -5.4% | -12.1% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 2.6% |
11.4% |
9.4% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses